Indications and uses
Uses spray to reduce bacteria on the skin.
Uses spray to reduce bacteria on the skin.
for adults and children 2 years and olde, apply to human body, allow to dry without wiping, ask a doctor before using on children under 2 years.
Didecyldimethyl Ammonium 0.3%
Triclosan 0.3%
Borneol 0.4%
Benzalkonium Bromide 0.3%
Antibacterial
If swallowed, get medical help or contact a Poison Control Center.
if you are allergic to any of the ingredients.
do not get into eyes. If eye contact occurs, rinse thoroughly with water.
irritation or redness develops, and continues for more than 72 hours.
Uses spray to reduce bacteria on the skin.
For external use only.
for adults and children 2 years and olde, apply to human body, allow to dry without wiping, ask a doctor before using on children under 2 years.
Polyethylene Glycol, Menthol, Water
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 58686-013-01 | 2019-11-27 | C162847 | 48780-1 | 9855d018-ea5c-cd31-e053-dbdaa90ab51a | SHUNFA ANTI-BACTERIA SPRAY |
| 58686-013-02 | 2019-11-27 | C162847 | 48780-1 | 9855d018-ea5c-cd31-e053-dbdaa90ab51a | SHUNFA ANTI-BACTERIA SPRAY |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 58686-013-01 | Shunfa Anti-Bacteria Spra | 30 mg in 1 BOTTLE, SPRAY | SPRAY | 30 | 2930 | |
| 58686-013-02 | Shunfa Anti-Bacteria Spra | 5 mg in 1 BOTTLE, SPRAY | SPRAY | 5 | 2930 |
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 58686-013 | SHUNFA ANTI-BACTERIA SPRA (DIDECYLDIMETHYL AMMONIUM,TRICLOSAN, BORNEOL, BENZALKONIUM BROMIDE) SPRAY [CHENGDU SHUNFA DISINFECTION AND WASHING TECHNOLOGY CO LTD] | 2930 | Legacy NDC, 2 package rows | 20130606_92cf6f49-d10b-49da-9d36-0aaef95ad6c2.zip |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| BENZALKONIUM BROMIDE | ACTIVE INGREDIENT | 151T1GQ42D | 2930 | |
| BORNEOL | ACTIVE INGREDIENT | M89NIB437X | 2930 | |
| DIDECYLDIMETHYLAMMONIUM | ACTIVE INGREDIENT | Z7F472XQPA | 2930 | |
| TRICLOSAN | ACTIVE INGREDIENT | 4NM5039Y5X | 2930 | |
| BENZALKONIUM BROMIDE | ACTIVE MOIETY | 151T1GQ42D | 2930 | |
| BORNEOL | ACTIVE MOIETY | M89NIB437X | 2930 | |
| DIDECYLDIMETHYLAMMONIUM | ACTIVE MOIETY | Z7F472XQPA | 2930 | |
| TRICLOSAN | ACTIVE MOIETY | 4NM5039Y5X | 2930 | |
| MENTHOL | INACTIVE INGREDIENT | L7T10EIP3A | 2930 | |
| POLYETHYLENE GLYCOL 1000 | INACTIVE INGREDIENT | U076Q6Q621 | 2930 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 2930 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 58686-013 | 58686-013-01, 58686-013-02 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| DIDECYLDIMETHYLAMMONIUM | Z7F472XQPA | ACTIB |
| TRICLOSAN | 4NM5039Y5X | ACTIB |
| BENZALKONIUM BROMIDE | 151T1GQ42D | ACTIB |
| BORNEOL | M89NIB437X | ACTIB |
| POLYETHYLENE GLYCOL 1000 | U076Q6Q621 | IACT |
| MENTHOL | L7T10EIP3A | IACT |
| WATER | 059QF0KO0R | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| MENTHOL | MENTHOL | L7T10EIP3A | CAPSULE / ORAL | 0.87 mg | ||
| MENTHOL | MENTHOL | L7T10EIP3A | SYRUP / ORAL | 7.5 mg/5ml | ||
| MENTHOL | MENTHOL | L7T10EIP3A | POWDER, FOR SOLUTION / ORAL | NA | ||
| MENTHOL | MENTHOL | L7T10EIP3A | AEROSOL, SPRAY / RESPIRATORY (INHALATION) | 0.02 %w/w | ||
| MENTHOL | MENTHOL | L7T10EIP3A | SOAP / TOPICAL | 0.75 %w/w | ||
| MENTHOL | MENTHOL | L7T10EIP3A | DROPS / OPHTHALMIC | NA | ||
| POLYETHYLENE GLYCOL 1000 | POLYETHYLENE GLYCOL 1000 | U076Q6Q621 | CREAM / TOPICAL | 0.5 %w/w | ||
| MENTHOL | MENTHOL | L7T10EIP3A | INHALANT / NASAL | 32 mg | ||
| MENTHOL | MENTHOL | L7T10EIP3A | CREAM / TOPICAL | 0.1 %w/w | ||
| MENTHOL | MENTHOL | L7T10EIP3A | CONCENTRATE / ORAL | 0.05 mg/5ml | ||
| POLYETHYLENE GLYCOL 1000 | POLYETHYLENE GLYCOL 1000 | U076Q6Q621 | CONCENTRATE / ORAL | 100 mg/1ml | ||
| MENTHOL | MENTHOL | L7T10EIP3A | SOLUTION, CONCENTRATE / ORAL | 0.5 mg/1ml | ||
| POLYETHYLENE GLYCOL 1000 | POLYETHYLENE GLYCOL 1000 | U076Q6Q621 | SUPPOSITORY / RECTAL | 1658 mg | ||
| MENTHOL | MENTHOL | L7T10EIP3A | SUSPENSION / ORAL | 1 mg | ||
| POLYETHYLENE GLYCOL 1000 | POLYETHYLENE GLYCOL 1000 | U076Q6Q621 | AEROSOL, FOAM / TOPICAL | NA | ||
| MENTHOL | MENTHOL | L7T10EIP3A | PASTE, DENTIFRICE / DENTAL | 4.7 %w/w | ||
| MENTHOL | MENTHOL | L7T10EIP3A | SOLUTION / ORAL | 3 mg | ||
| POLYETHYLENE GLYCOL 1000 | POLYETHYLENE GLYCOL 1000 | U076Q6Q621 | SOLUTION / ORAL | 1000 mg/5ml | ||
| MENTHOL | MENTHOL | L7T10EIP3A | DROPS / NASAL | 40.32 mg | ||
| POLYETHYLENE GLYCOL 1000 | POLYETHYLENE GLYCOL 1000 | U076Q6Q621 | TABLET, FILM COATED / ORAL | 1.52 mg | ||
| MENTHOL | MENTHOL | L7T10EIP3A | TABLET / ORAL | 0.58 mg | ||
| POLYETHYLENE GLYCOL 1000 | POLYETHYLENE GLYCOL 1000 | U076Q6Q621 | GEL / TOPICAL | 50 mg | ||
| POLYETHYLENE GLYCOL 1000 | POLYETHYLENE GLYCOL 1000 | U076Q6Q621 | GEL / TRANSDERMAL | 0.5 %w/w | ||
| MENTHOL | MENTHOL | L7T10EIP3A | TABLET / SUBLINGUAL | 2 mg | ||
| MENTHOL | MENTHOL | L7T10EIP3A | TABLET, ORALLY DISINTEGRATING / ORAL | 14 mg | ||
| MENTHOL | MENTHOL | L7T10EIP3A | GEL / TOPICAL | 0.1 %w/w | ||
| MENTHOL | MENTHOL | L7T10EIP3A | MOUTHWASH / BUCCAL | 0.15 mg/1ml | ||
| POLYETHYLENE GLYCOL 1000 | POLYETHYLENE GLYCOL 1000 | U076Q6Q621 | SUPPOSITORY / VAGINAL | NA | ||
| MENTHOL | MENTHOL | L7T10EIP3A | SOLUTION / DENTAL | NA | ||
| MENTHOL | MENTHOL | L7T10EIP3A | GUM, CHEWING / BUCCAL | 89 mg | ||
| MENTHOL | MENTHOL | L7T10EIP3A | JELLY / NASAL | 32.5 mg | ||
| MENTHOL | MENTHOL | L7T10EIP3A | LOTION / TOPICAL | 0.05 %w/w | ||
| MENTHOL | MENTHOL | L7T10EIP3A | AEROSOL, METERED / RESPIRATORY (INHALATION) | 0.02 %w/w |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| a12a1bd5-c7b7-400f-a8f3-7c7350b61edd | 92cf6f49-d10b-49da-9d36-0aaef95ad6c2 | 2013-06-05 | Warnings | a12a1bd5-c7b7-400f-a8f3-7c7350b61edd 92cf6f49-d10b-49da-9d36-0aaef95ad6c2 |
Adverse event summaries are temporarily unavailable. Other product information remains available.